Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial

Clinical trial NCT04690283 · UNKNOWN

Trial details

NCT number: NCT04690283
Sponsor: Nanjing NingQi Medicine Science and Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy Colorectal Cancer

Start date: 2021-01-01
Primary completion: 2022-07-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.